Metformin Is Associated With a Lower Risk of Atrial Fibrillation and Ventricular Arrhythmias Compared With Sulfonylureas: An Observational Study

Abstract

[Figure: see text].

Keywords: atrial fibrillation; metformin; propensity score; thiazolidinediones; ventricular fibrillation.

Figures

Figure 1.

Scheme of study design, comparing antidiabetic drug monotherapies

Figure 2.

Scheme of study design, pairwise comparison of antidiabetic combo-therapies with metformin

Figure 3.

Central illustration